Volume 22, Issue 3 - Health Economics and Market Access
European network for health technology assessment – EUnetHTA
Authors: Julia Chamova, Julie Lange
Abstract
In 2004, health technology assessment (HTA) was recognised as a ‘political priority’ by the EC and Council of Ministers, which led to a call to establish an effective and sustainable European network for HTA (EUnetHTA). The result was the establishment of the EUnetHTA Project in 2006. Since then, the work of this network for cross-border HTA cooperation within Europe has continued through various phases. The most innovative deliverable is the HTA Core Model® - a methodological framework that facilitates the production and sharing of HTA information. The current, Joint Action 2, phase of EUnetHTA aims to strengthen both the practical application of its tools and approaches to cross-border HTA collaboration, and to deliver recommendations on the implementation of a sustainable EUnetHTA.
Download the full article
References
- Kristensen FB, Mäkelä M, Neikter SA, Rehnqvist N, Håheim LL, Mørland B, et al. Planning, development, and implementation of a sustainable European network for health technology assessment. Int J Technol Assess Health Care 2009;25(Suppl. 2):84–91.
- EUnetHTA. A new application of the HTA Core Model – the HTA Core Model for Rapid Relative Effectiveness Assessment of pharmaceuticals [cited 2013 June 4]. Available from: http://www.eunethta.eu/outputs/new-application-hta-core-model-hta-core-model-rapid-relative-effectiveness-assessment-pharma
- EVIDENT – Evidence database on new technologies. [cited 2013 June 11]. Available from: https://www.evident.has-sante.fr/has/login.xhtml
- EUnetHTA POP database. [cited 2013 June 11] Available from: http://www.eunethta.dimdi.de/PopDB/HomePage.xhtml
- Directive 2011/24/EU of the European Parliament and of the Council of 9 March 2011 on the application of patients' rights in cross-border healthcare. Off J Eur Union L88/45 [2011 April 4 Available from: http://www.eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2011:088:0045:0065:EN:PDF
Visit the EMWA website
Search
Articles
Member Login
Links
Editoral Board
Editor-in-Chief:
- Phillip Leventhal (4Clinics, Lyon, France)
Co-Editor:
- Evguenia Alechine
- Stephen Gilliver (TFS Trial Form Support, Lund, Sweden)
Managing Editor
- Victoria White (Tampa, Florida, USA) Email: MEW@emwa.org
Associate Editors:
- Anuradha Alahari (PAREXEL International, Paris, France)
- Raquel Billiones (Clinipace, Zurich, Switzerland)
- Barbara Grossman (Hawkeye Medical Limited, Berkshire, UK)
- Joselita T Salita (Freelance, Bremen, Germany)
- Nathan Susnik (Hanover Medical School, Hanover, Germany)
- Clare (Chi-Chih) Chang
- Jonathan Pitt
Section Editors:
- Alison McIntosh (ICON Clinical Research, Hampshire, UK)
- Wendy Kingdom (Wendy Kingdom Ltd., Dulverton, UK)
- Lisa Chamberlain-James (Trilogy Writing and Consulting, Norfolk, UK)
- Maria Koltowska-Haggstrom (Proper Medical Writing Warsaw, Poland)
- Laura Collada Ali (Teksema, Cogne, Italy)
- Hervé Maisonneuve (Freelance, Lyon, France)
- Satyen Shenoy (Describe Scientific Writing & Communications, Cologne, Germany)
- Claire Gudex (Klinisk Institut, Odense, Denmark)
- Beatrix Doerr
- Sam Hamilton (Newcastle Upon Tyne, UK)
Ad-hoc Editors:
- Amy Whereat (SpeaktheSpeech Consulting, Asnieres sur Seine, France)
Editor Emeritus:
- Elise Langdon-Neuner (Medical University of Vienna, Austria)